Imaging Biometrics Ltd. (FRA:5Y1)

Germany · Delayed Price · Currency is EUR

0.0005

0.00 (0.00%)

Last updated: Oct 23, 2026, 8:04 AM CEST

Market Cap	2.58M -7.4%
Revenue (ttm)	941.17K +15.8%
Net Income	-275.74K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,425
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0035
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Imaging Biometrics

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood volume maps; IB Delta T1 maps, an image processing tool kit containing f... [Read more]

Industry Prepackaged Software

Sector Healthcare

Founded 1965

Employees 7

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5Y1

Financial Performance

In 2025, Imaging Biometrics's revenue was 788,148, an increase of 5.07% compared to the previous year's 750,105. Losses were -400,940, 22.6% more than in 2024.

Financial numbers in GBP Financial Statements